Cargando…
Is Carboxypeptidase B1 a Prognostic Marker for Ductal Carcinoma In Situ?
SIMPLE SUMMARY: Ductal carcinoma in situ (DCIS) is an early-stage breast cancer (BC), in which tumor cells are growing in a localized duct of the mammary gland. DCIS is considered a precursor disease for invasive BC and, therefore, treated as soon as it is identified. However, low-grade DCIS can be...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038727/ https://www.ncbi.nlm.nih.gov/pubmed/33917306 http://dx.doi.org/10.3390/cancers13071726 |